BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37898705)

  • 1. Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia.
    Zhang Z; Huang R; Lai Y
    Sci Rep; 2023 Oct; 13(1):18489. PubMed ID: 37898705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analysis of a novel small nucleolar RNAs prognostic signature in patients with acute myelocytic leukemia.
    Huang R; Liao X; Li Q
    Math Biosci Eng; 2022 Jan; 19(3):2424-2452. PubMed ID: 35240791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
    Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
    Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
    Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y
    Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
    Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
    BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
    Zhu Y; He J; Li Z; Yang W
    BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
    Huang R; Liao X; Wang X; Li Q
    J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
    Chen Y; Qiu X; Liu R
    BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
    Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
    Lai Y; Sheng L; Wang J; Zhou M; OuYang G
    Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
    Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
    Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of STAT4 as a prognostic biomarker in acute myeloid leukemia.
    Li C; Zhao J; Kang B; Li S; Tang J; Dong D; Chen Y
    Biosci Rep; 2024 Feb; 44(2):. PubMed ID: 38294290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.
    Jiang F; Mao Y; Lu B; Zhou G; Wang J
    Sci Rep; 2021 Jul; 11(1):14657. PubMed ID: 34282207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia.
    Zhu H; Xu Y; Xia J; Guo X; Fang Y; Fan J; Li F; Wu J; Zheng G; Liu Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14965-14982. PubMed ID: 37606761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
    Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.